Spectros T-Stat

Spectros Board and Advisors


Board of Directors

David Benaron
CEO

David Benaron is a founder of multiple biotechnology start-ups, including Spectros, FirstScan (in oncology), Xenogen (in Drug Discovery tools, public in 2004 and acquired by Caliper in 2006), and Insite (in oximetry and glucose monitoring, spun out to Vital Insite for Blood pressure monitoring with technology acquired by Masimo).

Benaron has an MD from Harvard, a Health Sciences degree from MIT, and attended as a physician in Intensive Care at Stanford University Medical School. He holds over 30 US and International patents in biomedical devices, methods, and technology. He serves on the Board at 2 companies outside of Spectros.




Israel Beinglass
Former CTO, Applied Materials

Israel Beinglass, former CTO at Applied Materials (Nasdaq: AMAT), joined the Board of Directors at Spectros Corporation in 2007. Before joining Applied Materials, Beinglass worked at Intel Corporation and IMP. While working at Intel he was the co-inventor of the Selective Tungsten Deposition. Dr. Beinglass has a Ph.D degree from the Hebrew University of Jerusalem in materials science and holds 28 US patents. Currently Beinglass is a consultant to multiple semiconductor equipment concerns, and serves on the BOD and advisory boards at several start ups.

Dr. Israel Beinglass, Spectros BOD


Richard Levenson
Cambridge Research Instruments (CRI)
Director, R&D

Richard Levenson, Chairman of the Board at Spectros, is Director of Research at Cambridge Research Instruments, a leading provider of tools for Molecular Imaging, joined the Board of Directors at Spectros Corporation in 2006. Levenson has promoted and expanded the tools available in Molecular Imaging while at CRI.

Dr. Richard Levenson, Spectros BOD


John Brock-Utne, MD
Stanford Medical School
Department of Anesthesiology

Dr. John Brock-Utne, is a senior Anesthesiologist at Stanford University Hospital. He provides medical practice and hospital economics insight and serves as a non-investor, independent voice on the Board of Directors at Spectros.

Dr. John Brock-Utne, Spectros BOD

Scientific Advisory Board

Boris Rubinsky
University of California at Berkeley

As a Professor of Bioengineering and Mechanical Engineering, Boris Rubinsky has been closely associated with a number of biomedical companies, including the first cryoablation company in the U.S., Cryomedical Systems (CMS). He continues this work with ablation devices for the breast and prostate. His Site Map interest focuses on heat and mass transfer in bioengineering with particular emphasis on low temperature biology and cryosurgery, and on introducing imaging systems (such as MRI and Electrical Impedance Tomography) in the control loop of minimally invasive surgical procedures.





Darryl Bornhop
Vanderbilt University
Professor of Chemistry

Darryl Bornhop has been an early advocate of, and leader in, the field of contrast agent development and optical imaging.


Irving Bigio
Boston University
Professor, Department of Biomedical Engineering,
Biomedical Optics Laboratory

Dr. Bigio is a leader in the field of monitoring tissues with light.


David Boas
Harvard Medical School / Massachusetts General Hospital
Professor, Radiology

Dr. Boas is a leader in the imaging of tissue using light.




Top

Dr. David Boas, Spectros Advisory Board


Medical Advisory Board

Spectros has a broad based and strong medical advisory board, with advisors in Radiology, Surgery, Gastroenterology, Anesthesia, and Intensive Care.

Top



©2008 Spectros Corporation | Contact Us